{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:34:11Z","timestamp":1793392451666,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.nmd.2021.05.009","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T10:19:30Z","timestamp":1622369970000},"page":"695-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The phenotypic and genotypic features of a Scottish cohort with McArdle disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Sacha E.","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Longman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.H.","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"T\u00f6pf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.05.009_bib0001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncpneuro0913","article-title":"McArdle disease: what do neurologists need to know?","volume":"4","author":"Lucia","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.nmd.2021.05.009_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/jnnp.55.5.407","article-title":"McArdle's disease with late-onset symptoms: case report and review of the literature","volume":"55","author":"Felice","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.05.009_bib0003","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: a clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.05.009_bib0004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry","volume":"83","author":"Lucia","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.05.009_bib0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12864-017-4188-2","article-title":"Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update","volume":"18","author":"Santalla","year":"2017","journal-title":"BMC Genom"},{"key":"10.1016\/j.nmd.2021.05.009_bib0006","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","article-title":"A metabolic myopathy due to absence of muscle phosphorylase","volume":"30","author":"Pearson","year":"1961","journal-title":"Am J Med"},{"key":"10.1016\/j.nmd.2021.05.009_bib0007","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1590\/0004-282X20140062","article-title":"From exercise intolerance to functional improvement: the second wind phenomenon in the identification of McArdle disease","volume":"72","author":"Scalco","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nmd.2021.05.009_bib0008","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2006.04.017","article-title":"Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping","volume":"124","author":"Rommel","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.nmd.2021.05.009_bib0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13023-020-01562-x","article-title":"Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)","volume":"15","author":"Scalco","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2021.05.009_bib0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00415-006-0447-x","article-title":"Analysis of spectrum and frequencies of mutations in McArdle disease: identification of 13 novel mutations","volume":"254","author":"Deschauer","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.05.009_bib0011","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nmd.2006.12.014","article-title":"Molecular characterisation of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype phenotype correlation","volume":"17","author":"Aquaron","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.05.009_bib0012","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ophtha.2018.09.013","article-title":"Retinopathy associated with biallelic mutations in PYGM (McArdle disease)","volume":"126","author":"Mahroo","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nmd.2021.05.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/S0960-8966(18)30404-8","article-title":"Evaluating the 12-minute walk test in McArdle disease","volume":"28","author":"Chatfield","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.05.009_bib0014","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41436-020-0840-3","article-title":"Sequential targeted whole exome sequencing of 1,001 patients affected by unexplained limb\u2013girdle weakness","volume":"22","author":"T\u00f6pf","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2021.05.009_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.21351","article-title":"Permanent muscle weakness in McArdle disease","volume":"40","author":"Nadaj-Pakleza","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.05.009_bib0016","doi-asserted-by":"crossref","first-page":"E1267","DOI":"10.1152\/ajpendo.00526.2001","article-title":"Decreased insulin action in skeletal muscle from patients with McArdle's disease","volume":"282","author":"Nielsen","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nmd.2021.05.009_bib0017","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22806","article-title":"McArdle disease: update of reported mutations and polymorphisms in the PYGM gene","volume":"36","author":"Nogales-Gadea","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.05.009_bib0018","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.nmd.2017.06.004","article-title":"Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease","volume":"27","author":"Inal-G\u00fcltekin","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.05.009_bib0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM199307223290404","article-title":"Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease)","volume":"329","author":"Tsujino","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2021.05.009_bib0020","first-page":"53","article-title":"McArdle disease: molecular genetic update","volume":"26","author":"Andreu","year":"2007","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2021.05.009_bib0021","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10545-018-0203-2","article-title":"Manifesting heterozygotes in McArdle disease: a myth or reality \u2013 role of statins","volume":"41","author":"N\u00fa\u00f1ez-Manch\u00f3n","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2021.05.009_bib0022","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","article-title":"Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle Disease","volume":"132","author":"Vissing","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.05.009_bib0023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2007.06.025","article-title":"Genotype modulators of clinical severity in McArdle disease","volume":"422","author":"Rubio","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nmd.2021.05.009_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.10499","article-title":"etl al","volume":"53","author":"Martinuzzi","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.05.009_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bjsm.2007.038992","article-title":"The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease","volume":"42","author":"G\u00f3mez-Gallego","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.nmd.2021.05.009_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nmd.2007.04.006","article-title":"The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle's disease","volume":"17","author":"Lucia","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.05.009_bib0027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM199307223290404","article-title":"Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease)","volume":"329","author":"Tsujino","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2021.05.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003458.pub5","article-title":"Pharmacological and nutritional treatment for McArdle disease (Glycogen storage disease type V)","author":"Quinlivan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2021.05.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003458.pub3","article-title":"Pharmacological and nutritional treatment for McArdle disease (Glycogen storage disease type V)","author":"Quinlivan","year":"2008","journal-title":"Cochrane Database of Syst Rev"},{"issue":"12","key":"10.1016\/j.nmd.2021.05.009_bib0030","article-title":"Physical training for McArdle disease","volume":"7","author":"Quinlivan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2021.05.009_bib0031","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/mus.20251","article-title":"Exercise tolerance and daily life in McArdle's disease","volume":"31","author":"Ollivier","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.05.009_bib0032","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1249\/MSS.0000000000000458","article-title":"Cardiorespiratory fitness, physical activity, and quality of life in patients with McArdle disease","volume":"47","author":"Mungu\u00eda-Izquierdo","year":"2015","journal-title":"Med Sci Sports Exerc"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:56Z","timestamp":1793390876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0960896621001346"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.05.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phenotypic and genotypic features of a Scottish cohort with McArdle disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}